pilot study neoadjuvant chemotherapy cisplatin surgical resection postoperative radiation therapy and/or chemotherapy adenocarcinoma esophagus Fifteen patients resectable adenocarcinoma esophagus cycles preoperative chemotherapy cisplatin DDP Response chemotherapy comparative barium swallow chest tomography esophagoscopy change clinical symptomatology Eleven patients inoperable surgery death toxicity due progressive disease eleven patients gross residual tumor patient residual microscopic disease patient complete clinical responses CCR partial clinical response PCR response NR patients resected patients free disease Median survival time months patients months resected patients 